Dr. Brite LLC

Form 483 issued April 5, 2024 · Fullerton, California

Inspection
Apr 2 – Apr 5, 2024
Investigator
Andrew Le
Observations
6
Pages
6
FEI number
3016665985

In short: On April 5, 2024, FDA issued a Form 483 with 6 observations to Dr. Brite LLC in Fullerton, California (FEI 3016665985) after an inspection that ran Apr 2 – Apr 5, 2024. The investigator was Andrew Le. Most observations concern production and laboratory controls.

At a glance

Production and laboratory controls account for 4 of 6 observations.

Production2
Laboratory controls2
Quality system1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Batch production and control records do not include complete information relating to the production and…

  3. 03

    The identity of each component of a drug product is not verified by conducting at least…

  4. 04

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dr. Brite LLC?

FDA listed 6 observations on this Form 483, mostly about production, laboratory controls and quality system. The opening words of each observation are shown on this page.

Who inspected Dr. Brite LLC?

Andrew Le is named on this Form 483, for the inspection of Apr 2 – Apr 5, 2024. Each investigator has a profile showing what they cite most.

When was Dr. Brite LLC inspected by FDA?

The inspection ran Apr 2 – Apr 5, 2024, and the Form 483 is dated April 5, 2024.

How do I get the full Form 483 for Dr. Brite LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free